Nuvilex to Issue Positive Shareholder ...(. Presently the Last Shot Hangover Remed...),Health

Date:8/25/2009

. Presently the Last Shot Hangover Remedy, Prevorex and the Company's cosmetics and skin care products are well suited as "Quick Strike" products. Quick Strike products are those that can effectively market either directly or indirectly developing brand awareness and wide distribution within twelve to eighteen months. To financially support our Quick Strike products, the sale of certain product marketing and/or distribution rights, for example international market rights, may be necessary.

Partnering for long-term success. Currently we have a partner, a multi-billion dollar private agricultural products company, who will be assisting us with the final phases of development and commercialization of Oraphyte for the turf grass industry. We are currently discussing a co-development and commercialization contract for crop protection with a Fortune 100 company. Commercial partners can hasten, through their experience and established market position, product development, introduction and global sales penetration. There is, however, a corresponding cost. If we assume that our partners will bear substantially all of the brand development and distribution costs, our share of the revenues and profits from partnered products will be substantially lower than non-partnered products. We believe, however, for products like Oraphyte maximum market penetration can only be achieved through partnerships with established companies.

Out-license to financially support more robust opportunities. As previously identified, our challenge is to become a skilled marketing company. This will require us to hire talented people and/or engage outside resources in support of building and executing effective marketing programs. Within our product and technology portfolio, we have intellectual property (patents) and product assets of value that could be either sold or licensed. The proceeds from these activities, which typically include milestone and royalty payments, wou
'/>"/>

SOURCE Nuvilex, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Nuvilex Completes First Sale of Last Shot Hangover Remedy(TM)
2. Nuvilex, Inc. Announces Business Update Conference Call
3. Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health
4. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
5. Nuvilex Featured in Wall Street Reporter Interview
6. Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest
7. Nuvilex Launches Video Marketing Campaign
8. Nuvilex Gets Update from CK41 on purEffect(TM) Launch Plan
9. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
10. Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex
11. Nuvilex, Inc. Announces Monthly Investor Conference Call